D.E. Shaw & Co’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,559
Closed -$515K 4621
2025
Q4
$515K Buy
+28,559
New +$513K ﹤0.01% 3919
2025
Q3
Sell
-18,854
Closed -$302K 4616
2025
Q2
$302K Sell
18,854
-227,488
-92% -$4.06M ﹤0.01% 3869
2025
Q1
$4.79M Sell
246,342
-864,159
-78% -$18.2M 0.01% 1924
2024
Q4
$24.5M Buy
1,110,501
+155,086
+16% +$2.98M 0.03% 917
2024
Q3
$16.1M Buy
955,415
+565,303
+145% +$8.39M 0.02% 1123
2024
Q2
$4.66M Sell
390,112
-335,034
-46% -$3.74M 0.01% 1909
2024
Q1
$8.03M Buy
725,146
+254,038
+54% +$2.59M 0.01% 1532
2023
Q4
$4.08M Buy
471,108
+315,488
+203% +$2.45M 0.01% 2071
2023
Q3
$1.19M Buy
155,620
+95,028
+157% +$713K ﹤0.01% 2957
2023
Q2
$436K Buy
+60,592
New +$353K ﹤0.01% 3474
2022
Q2
Sell
-13,046
Closed -$83K 5394
2022
Q1
$83K Sell
13,046
-2,698
-17% -$17.9K ﹤0.01% 5037
2021
Q4
$126K Buy
+15,744
New +$148K ﹤0.01% 5014

Other funds holding CLBT